For research use only. Not for therapeutic Use.
6-Methylpurine riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Catalog Number | M053742 |
| CAS Number | 14675-48-0 |
| Synonyms | (2R,3R,5R)-2-(hydroxymethyl)-5-(6-methylpurin-9-yl)oxolane-3,4-diol |
| Molecular Formula | C11H14N4O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C11H14N4O4/c1-5-7-10(13-3-12-5)15(4-14-7)11-9(18)8(17)6(2-16)19-11/h3-4,6,8-9,11,16-18H,2H2,1H3/t6-,8+,9?,11-/m1/s1 |
| InChIKey | FIGBCBGMUIGJBD-GBDDODFYSA-N |
| SMILES | CC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
